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Background: The objective of this study was to conduct a systematic review with meta-analysis of studies
assessing the association between living in an urban environment and the development of the Crohn’s disease
(CD) or ulcerative colitis (UC).
Methods: A systematic literature search of MEDLINE (1950-Oct. 2009) and EMBASE (1980-Oct. 2009) was conducted
to identify studies investigating the relationship between urban environment and IBD. Cohort and case–control
studies were analyzed using incidence rate ratio (IRR) or odds ratio (OR) with 95 % confidence intervals (CIs),
respectively. Stratified and sensitivity analyses were performed to explore heterogeneity between studies and assess
effects of study quality.
Results: The search strategy retrieved 6940 unique citations and 40 studies were selected for inclusion. Of these,
25 investigated the relationship between urban environment and UC and 30 investigated this relationship with CD.
Included in our analysis were 7 case–control UC studies, 9 case–control CD studies, 18 cohort UC studies and 21
cohort CD studies. Based on a random effects model, the pooled IRRs for urban compared to rural environment for
UC and CD studies were 1.17 (1.03, 1.32) and 1.42 (1.26, 1.60), respectively. These associations persisted across
multiple stratified and sensitivity analyses exploring clinical and study quality factors. Heterogeneity was observed in
the cohort studies for both UC and CD, whereas statistically significant heterogeneity was not observed for the
case–control studies.
Conclusions: A positive association between urban environment and both CD and UC was found. Heterogeneity
may be explained by differences in study design and quality factors.
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The etiology of the inflammatory bowel diseases (IBD)
has been extensively studied [1], however, the environ-
mental determinants of disease pathogenesis are not
fully understood [2,3]. IBD is widely believed to be asso-
ciated with industrialization of nations. This hypothesis
is supported by the significant geographic variation in* Correspondence: ggkaplan@ucalgary.ca
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reproduction in any medium, provided the orIBD with the highest incidence rate of IBD in North
America and Europe [4]. Migrant studies have demon-
strated that immigrants, and particularly their offspring,
from low prevalent regions acquire a similar risk of IBD
as the local population [5]. Furthermore, the incidence
of IBD is steadily rising in several developing nations as
they have become industrialized [6,7]. Within a country
the incidence of IBD has been proposed to be higher in
urban versus rural areas [8,9].
Although numerous studies have investigated the asso-
ciation between urban environment and IBD, findings
remain inconsistent. An urban association has been con-
sidered as far back as 1963, when Acheson and Nefzgertd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and ulcerative colitis (UC) [10]. Many observational
studies have subsequently shown an increase in UC and
Crohn's disease (CD) incidence in more densely popu-
lated areas [8,11-15]. Numerous studies, however, have
failed to find an association between urban exposure and
IBD [4,16], while others have shown an inverse associ-
ation [17]. Establishing whether the risk of IBD is greater
in urban environments is important because environ-
mental exposures in urban societies are significantly dif-
ferent than those in rural areas. This information may
direct research initiatives on specific environmental risk
factors of IBD and establish distribution of IBD burden
in society.
A systematic analysis of the association between living in
an urban environment and IBD has yet to be conducted.
Thus, we performed a systematic review and meta-analysis
of all case–control and cohort studies that explored the
association between residing in an urban region and IBD
in order to determine whether the risk of CD and/or UC
was increased in urban as compared to rural areas.
Methods
Search strategy
We conducted a systematic literature search using a prede-
termined protocol and in accordance with the quality of
reporting meta-analyses of observational studies (MOOSE)
[18]. We searched two computer-stored databases, Med-
line (1950-present) and Embase (Excerpta Medica Data-
base; 1980-present) for studies describing the association
between urban environment and IBD as of October
2009. The search strategy for Medline and Embase was
conducted based on three themes. The first theme, the
outcome measure, combined the exploded version of
Medical Subject Headings (MESH) “inflammatory bowel
disease” or “Colitis, Ulcerative” or “Crohn Disease”. The
second theme, the exposure, combined the exploded ver-
sion of MESH headings “urban population” or “urban
health” or “rural population” or “rural health” or “geog-
raphy”. The third theme combined exploded versions of
MESH headings “risk factors” or “risk assessment” or
“epidemiology” or “demography”. All the keywords were
used to search the titles and abstracts. The search was
not limited by language or human subjects to ensure
capture of all appropriate papers. Abstracts from the
American College of Gastroenterology for 2006, 2007,
and 2008, and the American Gastroenterological Associ-
ation for 2006 and 2007 were reviewed. The reference
lists of relevant articles were also reviewed.
Selection criteria
Two reviewers (N.M. and I.S.) identified articles eligible
for further review by performing an initial screen of
identified abstracts and titles. Articles were eliminated inthis initial screen if they were not observational or did
not either investigate environmental risk factors for IBD
in a case–control study or investigate epidemiology
of IBD using incident cases. Studies that did not report
original data and duplicated publications were also
excluded. Full-text of the remaining articles were
retrieved and systematically reviewed. Articles were con-
sidered for inclusion in the second screening if they
reported a measure of association between urban envir-
onment and UC and/or CD. In both study designs, UC
and CD were required to be reported separately for
inclusion into the systematic review. Studies that did not
report adequate information to calculate incidence rate
ratio (IRR) or odds ratio (OR) with 95% confidence
interval (CI) were excluded. Disagreement between
reviewers was resolved by consensus with third party
experts (DR and GK).
Data extraction
The outcome variable of interest was defined as the
presence of UC and/or CD. The exposure variable of
interest was residing in an urban versus rural environ-
ment. Urban and rural populations were not consistently
defined across all studies. Several studies (n = 10 for UC;
n = 11 for CD) did not define an urban and/or rural
environment [12,13,16,17,19-31]. The studies that defined
this exposure used definitions that varied and some
papers stratified by multiple levels of exposure (e.g. urban,
semi-urban, and rural) [24,32-36]. A priori we identified
studies that defined urban as a population greater than
10,000 [37,38]. Secondary variables extracted from the
manuscripts included: study design (i.e. case–control or
cohort); country of origin; publication year; timing of
exposure; source of controls for case–control studies; and
information on key indicators of study quality, using
MOOSE [18].
We extracted reported OR and IRR with 95% (CIs) or
data enabling the calculation of these association mea-
sures. Both adjusted and unadjusted values were extracted;
though, when available, the adjusted estimates were used.
Statistical analysis
Meta-analyses were initially conducted by combining
cohort and case–control studies using IRRs, defined as
the incidence rate of IBD in urban versus rural popula-
tions. Given the low prevalence of IBD, the OR would
approximate the IRR under the rare disease assumption.
Case–control and cohort studies were then analyzed
separately using different measures of association. The
IRR was used as measure of association for cohort
studies and OR was used for case–control studies. The
Test of Heterogeneity was performed using a Q statistic
(5% level) and random effects models were used
because of the presence of heterogeneity between studies.
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may explain heterogeneity between studies. Publication
year was a priori stratified into three year categories:
1962–1988; 1989–1998; and 1999–2009. Similarly, strati-
fied analyses and meta-regression were performed based
on study design (i.e. case–control or cohort study), region
of publication, timing of exposure, and source of controls
in case–control studies. Sensitivity analyses were per-
formed to exclude studies that did not include a definition
of urban/rural region. Further sensitivity analysis was
conducted on studies that used >10,000 people as a
definition of urban environment [37,38]. Papers that
stratified by multiple levels of exposure (e.g. urban, semi-
urban, and rural) were analyzed as urban versus rural.




The search strategy retrieved 6940 unique citations:
2964 from Medline and 3976 from Embase. Of these,
6434 citations were excluded after the first screening
based on titles and abstracts, leaving 506 articles for full-
text review (Figure 1). The observed agreement between
reviewers for eligibility of articles was 97%, correspond-
ing to a kappa statistic of 0.77. Upon full text review of
506 articles, 466 were excluded (see Figure 1 for ration-
ale of exclusions), leaving 40 studies for final inclu-
sion in the systematic review and meta-analysis. Of these
40 studies, 25 investigated the relationship between
urban environment and UC and 30 investigated thisFigure 1 Literature search results.relationship with CD. Included in our analysis were
7 case–control UC studies, 9 case–control CD studies,
18 cohort UC studies, and 21 cohort CD studies.
Demographic and study quality characteristics
Characteristics of the 18 cohort studies for UC are shown
in Table 1 [19-21,23,24,32-35,39-45]. The reported inci-
dence rate ranged from 0.97 to 15.6 per 100,000/year.
A definition for urban and/or rural environment was
provided for 13 cohort studies. Characteristics of the
7 selected case–control studies for UC are shown in
Table 2 [8,12,17,26-28,46]. Two of the studies had defini-
tions for urban and/or rural environment. Characteristics
of the 21 selected cohort studies for CD are shown in
Tables 1 [14,15,22,23,25,30,31,36,39-43,45,47-52]. The
reported incidence rate of CD ranged from 0.51 to 15.6
per 100,000/year. A definition for urban environment
was reported in 16 studies. Characteristics of the nine
selected case–control studies for CD are shown in Table 2
[8,13,16,17,27,29,46,53]. The studies were based in North
America, Australia, Asia and Europe. The association be-
tween urban environment and IBD was not the primary
outcome of interest in any of the cohort or case–control
studies.
Urban/rural environment and IBD
The pooled crude IRR for the 25 UC studies was 1.17
(1.03, 1.32) (Figure 2A). For the 18 cohort studies, the
pooled crude IRR was 1.19 (1.03, 1.36) (Figure 2B). In 13
of the studies, a positive association between UC and
urban environment was found, 7 of which were statistically
Table 1 Characteristics of cohort studies for ulcerative colitis and Crohn’s disease studies
Study characteristics and demographics Study Quality Characteristics
























Mate-Jimerez 1994[39] Spain 1981-88 111 3.16 Yes Yes Yes Yes At diagnosis No
Ekbom 1991[40] Sweden 1965-83 2509 10.5 Yes Yes Yes No At diagnosis No
Linden 1971[19] Finland 1967 223 4.76 No N/A No No At diagnosis No
Probert 1992[32] UK 1972-80 192 5.33 Yes Yes Yes No At diagnosis Yes
Probert 1992[32] UK 1981-89 211 7.29 Yes Yes Yes No At diagnosis Yes
Niv 1990[33] Israel 1967-86 43 2.33 Yes No Yes No At diagnosis Yes
Kildebo 1990[22] Norway 1983-86 179 13.2 Yes Yes No No At diagnosis No
Gheorghe 2004[23] Romania 2002-03 163 0.97 Yes Yes No No At diagnosis No
Sincic 2006[41] Croatia 2000-04 70 4.6 Yes Yes Yes No At diagnosis No
Tsianos 1994[24] Greece 1982-91 61 4.18 Yes Yes No No At diagnosis Yes
Ladas 2005[34] Greece 1990-94 56 10.6 Yes Yes Yes Yes At diagnosis Yes
Moller 1971[20] Finland 1956-67 505 1.07 Yes Yes No No At diagnosis No
Blanchard 2001[42] Canada 1987-96 1763 15.6 Yes Yes Yes No At diagnosis No
Green 2006[15] Canada 1990-01 N/A 13.5 No N/A Yes No At diagnosis No
Lakatos 2003[43] Hungary 1977-01 560 5.89 Yes Yes Yes No At diagnosis No
Manousos 1996[44] Greece 1990-94 117 8.9 Yes Yes Yes No At diagnosis No
Wigley 1962[35] New Zealand N/A 132 N/A Yes No Yes Yes At diagnosis Yes
Latour 1996[45] Belgium 1993-94 36 3.5 Yes Yes Yes No At diagnosis No
Crohn’s Disease
Kyle 1971[47] UK 1955-69 166 1.98 Yes Yes Yes No At diagnosis No
Jayanthi 1992[48] UK 1972-80 161 2.89 Yes Yes Yes Yes At diagnosis No
Jayanthi 1992[48] UK 1981-89 233 4.48 Yes Yes Yes Yes At diagnosis No
Mate-Jimerez 1994[39] Spain 1981-88 57 1.61 Yes Yes Yes Yes At diagnosis No
Ekbom 1991[40] Sweden 1965-83 1469 6.09 Yes Yes Yes No At diagnosis No
Shivananda 1987[36] Netherlands 1979-83 54 3.90 Yes Yes Yes No At diagnosis Yes
Kildebo 1989[22] Norway 1983-86 82 5.85 Yes Yes No No At diagnosis No
Kyle 1992[49] Scotland 1955-88 856 5.65 Yes Yes Yes No At diagnosis No
Manousos 1996[44] Greece 1990-94 37 3.00 Yes Yes Yes Yes At diagnosis No


















Table 1 Characteristics of cohort studies for ulcerative colitis and Crohn’s disease studies (Continued)
Sincic 2006[41] Croatia 2000-04 100 6.50 Yes Yes Yes No At diagnosis No
Phavichitr 2003[25] Australia 1971-01 351 1.02 Yes Yes No No At diagnosis No
Moum 1996[50] Norway 1990-93 225 5.86 Yes Yes Yes No At diagnosis No
Blanchard 2001[42] Canada 1987-96 1765 15.6 Yes Yes Yes No At diagnosis No
Green 2006[15] Canada 1990-01 N/A 14.8 No N/A Yes No At diagnosis No
Lakatos 2003[43] Hungary 1977-01 212 2.23 Yes Yes Yes No At diagnosis No
Nyhlin 1986[51] Sweden 1974-81 253 4.90 Yes Yes Yes No At diagnosis No
Ruiz Ochoa 1984[30] Spain 1976-83 152 0.80 Yes Yes No No At diagnosis No
Sedlack 1980[31] USA 1935-75 103 4.20 Yes No No No At diagnosis No
Brandes 1983[52] Germany 1964-75 97 3.00 Yes No Yes No At diagnosis No


















able 2 Characteristics of case–control studies for ulcerative colitis and Crohn’s disease studies
Study characteristics and demographics Study quality characteristics






















arrello 1997[26] Italy 509 657 Attending orthopedic
and surgical clinics
Sex, age, year of
diagnosis
Yes Yes No No Time of data collection No
eeney 2002[17] UK 137 137 Functional GI Disorders Sex, age Yes Yes No No Childhood (age 0–5) No
ernstein 2007[27] Canada 137 310 Manitoba Health
Population Registry
Sex, age No N/A No No N/A No
ang 2007[28] China 177 177 Neighbours or colleagues Sex, age Yes Yes No No Childhood No
adon 2007[54] Germany 304 1481 Strabismus surgery Age No N/A No No Time of data collection No
artinez Salmeron
994[46]
Spain 63 63 Hospital Sex, age Yes Yes Yes No Time of data collection No
kbom 1990[8] Sweden 164 328 Live births between
1924–1957 in Uppsala
County
Date of birth, sex,
and maternal age
or parity
Yes Yes Yes No Time of birth No
rohn’s Disease
eeney 2002[17] UK 139 139 Functional GI disorders Sex, age Yes Yes No No Childhood (age 0–5) No
ernstein 2007[27] Canada 235 310 Manitoba Health
Population Registry
Sex, age No N/A No No N/A No
onsonby 2009[53] Australia 278 998321 Live births from
1983–1998 in
Victoria
Age Yes No Yes No Childhood (age 0–6) No
alekzadeh 2009[16] Iran 196 207 IBS treated by an expert
gastroenterologist
Age Yes Yes No No Childhood
(before 16th birthday)
No
adon 2007[54] Germany 444 1481 Strabismus surgery Age No N/A No No Time of data collection No
hompson 1998[29] England, Wales 291 1682 Same GP Sex, age No N/A No No N/A No
urzelmann 1994[13] United States 322 262 Closest neighbour Sex, age, race No N/A No No Childhood (age 0–5) Yes
artinez Salmeron
994[46]
Spain 30 30 Hospital Sex, age Yes Yes Yes No Time of data collection No
kbom 1990[8] Sweden 93 186 Live births between
1924–1957 in Uppsala
County
Date of birth, sex,
and maternal age
or parity







































Figure 2 Forest plot of the summary effect estimate with 95% CI studies that explored the relationship between urban environment
and ulcerative colitis for both cohort and case–control studies (A); cohort studies (B); and case–control studies (C).
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Figure 3 Forest plot of the summary effect estimate with 95% CI studies that explored the relationship between urban environment
and Crohn’s disease for both cohort and case–control studies (A); cohort studies (B); and case–control studies (C).
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Table 3 Sensitivity and stratified analyses of pooled relative risk for cohort studies
Ulcerative colitis Crohn’s disease





















Crude 18 6901 1.19(1.03, 1.36) <.001 21 6514 1.50(1.30, 1.72) <.001
Definition of urban/rural environment
Urban/rural defined 13 5906 1.18(1.09, 1.27) .19 16 5741 1.28(1.14, 1.43) <.001
Urban defined as >10,000 3 299 1.16(0.90, 1.50) .65 4 488 1.38(0.97, 1.97) .072
Year of publication
1962-1988 3 860 0.96(0.60, 1.51) <.001 0.16 .30 6 825 1.90(1.27, 2.85) <.001 −0.095 .47
1989-1998 9 3459 1.23(0.95, 1.57) <.001 9 3176 1.26(1.04, 1.53) <.001
1999-2009 6 2612 1.30(1.10, 1.54) .022 6 2513 1.49(1.18, 1.87) .001
Region
European countries 15 5036 1.21(0.99, 1.46) <.001 0.008 .98 17 4295 1.55(1.28, 1.88) <.001 0.77 .75
Non-European countries 3 1895 1.13(1.06, 1.22) .61 4 2219 1.39(1.18 1.62) .12
European Countries
Northern 6 3819 0.97(0.75, 1.27) <.001 −0.26 .086 9 3499 1.23(1.04, 1.45) <.001 0.23 .04
Eastern 2 723 1.59(0.98, 2.59) .013 2 297 2.30(0.54, 9.82) <.001
Mediterranean 6 458 1.39(0.82, 2.36) <.001 4 346 2.64(1.50, 4.62) .02


















Table 4 Sensitivity and stratified analyses of pooled odds ratio for case–control studies
Ulcerative colitis Crohn’s disease

























Crude 7 1491 3153 1.06 (0.78, 1.45) .004 9 2028 1002618 1.26 (1.03, 1.53) .16
Time of exposure
Time of data collection 4 1013 2511 1.18 (0.78, 1.80) .006 -0.32 .42 2 474 1511 1.21 (0.58, 2.50) .18 0.060 .89
Childhood 3 478 642 0.87 (0.65, 1.17) .91 5 1028 999115 1.18 (0.82, 1.70) .052
0-6 years 4 832 998908 1.12 (0.71, 1.77) .026 0.16 .46
< 16 years 1 196 207 1.39 (0.74, 2.60) NA
Source of controls
Population 2 314 487 1.02 (0.66, 1.58) .16 0.035 .94 3 835 998893 1.40 (1.13, 1.73) .37 -0.23 .32
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(Q statistic, 95.14; P< .001). For the UC case–control
studies, the pooled OR for the association between urban
environment and UC was 1.06 (0.78, 1.45) (Figure 2C).
Three out of seven studies found a positive association,
and two were statistically significant. Heterogeneity was
observed across studies (Q statistic, 19.32; P= .004).
The pooled IRR for the 30 CD studies was 1.42 (1.26, 1.60)
(Figure 3A). For the 21 cohort studies, the pooled crude
IRR was 1.50 (1.30, 1.72) (Figure 3B). In 20 of the studies,
a positive association between CD and urban environ-
ment was found, 10 of which were statistically significant.
Heterogeneity across cohort studies was observed (Q stat-
istic, 108.56; P< .001). For the 9 CD case–control studies,
the pooled OR for the association between urban environ-
ment and CD was 1.26 (1.03, 1.53) (Figure 3C). Six out of
the seven studies found a positive association, but only
three were statistically significant. Heterogeneity was not
observed across studies (Q statistic, 11.88; P= .157).
Sensitivity and stratified analyses
After excluding the UC cohort studies that did not de-
fine urban and/or rural environment the pooled IRR was
1.18 (1.09, 1.27), which did not differ from the crude
pooled IRR (Table 3). The IRR lost significance 1.16 (0.9,
1.5) when we included only studies that defined urban
as >10,000 people. Only cohort studies published after
1999 demonstrated an association between urban envir-
onment and UC (1.30; 95% CI: 1.10, 1.54). A stratified
analysis was similarly performed for region in which
the study was based, divided into European and non-
European countries. The IRR for Non-European studies
was statistically significant with pooled estimate of 1.13
(1.06, 1.22). Meta-regression was not statistically signifi-
cant for year of publication, region of publication and
European countries.
For the UC case–control studies, we failed to find a sta-
tistically significant association when stratifying by timing
of exposure (Table 4). Meta-regression was performed for
both timing of exposure and source of controls and no
statistically significant associations were found.
After excluding CD cohort studies that did not define
urban and/or rural environment, the pooled IRR was
1.28 (1.14, 1.43), which was similar to the crude IRR
(Table 3). Restricting the urban definition to >10,000
people resulted in a loss of significance with an IRR
of 1.38 (0.97, 1.97). The pooled IRRs were statistically
significant across all 3 categories of publication year
(Table 3). A stratified analysis was similarly performed
for region in which the study was based, divided into
European and non-European countries. The IRRs for
both European and non-European studies were statisti-
cally significant with pooled estimates of 1.55 (1.28, 1.88)
and 1.39 (1.18, 1.62), respectively. In meta-regressionanalysis only the European countries variable was statisti-
cally significant (Table 3).
For the CD case–control studies, we failed to find a
statistically significant association when stratified by tim-
ing of exposure (Table 4). Meta-regression was per-
formed for both time of exposure and source of controls
and no statistically significant associations were found.
The OR for population-based controls was 1.40 (1.13,
1.73) and for hospital/clinic-based controls was 1.09
(0.79, 1.51). Meta-regression was performed for both
variables and no statistically significant result was found.
Publication bias
No publication bias was found; the Begg tests were not
statistically significant for UC (z =−0.42, P= .675) or CD
studies (z = 0.70, P= .487).
Discussion
Urbanization of society is an important risk factor for
the development of IBD. This meta-analysis suggests
that living in urban environments may increase the risk
of developing CD and UC. Though, the strengths of
association varied among the 40 studies due to hetero-
geneity between studies. The association between CD
and urban environment persisted across a number of
stratified analyses that explored clinical and study quality
factors. In contrast, the association between UC and
urban environment was weaker and less consistent upon
sensitivity analyses. Publication bias was not observed
suggesting that the association were likely not an artifact
of unpublished studies.
Several theories may explain the increased incidence of
IBD in urban societies. The Hygiene Hypothesis proposes
that the lack of early childhood exposure to enteric patho-
gens with improved sanitation in urban cities increases
the incidence of IBD [5,55]. The lack of exposure to
enteric pathogens may lead to a greater susceptibility to
develop an inappropriate immunologic response upon
exposure to new antigens (e.g. gastrointestinal infection)
later in life [56]. Other environmental risk factors of IBD
that are more predominant in urban societies include
smoking, lack of helminths exposure, and antibiotic use
[57-59]. Additionally, a recent study demonstrated that
air pollution in urban cities was associated with IBD in
children [60]. Urban occupations such as driving and
manufacturing have also been reported as risk factors for
IBD [61]. While a cohesive hypothesis that explains the
environmental determinants of IBD has not been proven,
this meta-analysis supports further research exploring
the environmental risk factors of urbanization and IBD.
Heterogeneity was observed in both the CD and UC
cohort studies, whereas statistically significant heterogen-
eity was not observed for the UC and CD case–control
studies. This inconsistency was likely due to the large
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an overpowered heterogeneity statistical test. In contrast,
the case–control studies were small in total study popu-
lation. Alternatively, differences in heterogeneity between
studies may be explained by the difference in the study
design and by the intrinsic biases associated with cohort
and case–control studies that explore environmental risk
factors of IBD.
When studies were stratified by region the association
between UC and urban environment persisted only in
non-European studies, whereas the association between
CD and urban environment remained significant in most
regions. Regional differences may be due to the fact that
studies originated from countries that differed by ethnicity,
prevalence of IBD, and rates of IBD susceptibility genes
[62,63]. Alternatively, the small number of studies in each
region made appropriate and meaningful inferences chal-
lenging. Furthermore, data was lacking for low prevalent
regions (i.e. developing world) and thus we could not
explore the urban/rural effect in these regions.
We explored whether the year of publication contribu-
ted to the heterogeneity observed between studies. For
UC, only publications after 1999 were significant after
pooling. This time stratified finding may be due to study
design differences in more recent publications or the
changing pattern of UC diagnosis. In contrast, the
urban/rural relationship persisted across all time strata
for CD, which suggested a greater strength of association
for CD over UC.
The definition of an urban environment was a source
of heterogeneity across studies. The studies that clearly
defined this exposure included population estimates of
the urban and/or rural areas; however, the inconsistency
or lack of definitions made study comparisons chal-
lenging. We a priori selected the definition of urban
as more than 10,000 people because this definition is
consistent with census of populations in many Countries
(e.g. United Kingdom [37] and Canada [38]). When con-
sidering only studies that defined urban as >10,000, the
association was no longer significant, which was likely
due to the small number of studies with this definition
(n = 2 for UC and n = 4 for CD). However, this finding
may also reflect that the risk associated with urban soci-
ety may be driven by greater population size (e.g. living
in a metropolis) and/or by population density. Ideally,
we would have investigated the potential for a dose
response effect to explore whether the risk of IBD
increased with increasing population sizes. However, few
papers stratified their results by multiple levels of expos-
ure; for example, Tsianos [24] and Ladas [34] stratified
their analysis into urban, semi-rural, and rural. Future
studies of the urban–rural association should explore
the importance of a dose response effect, a threshold
value of population size, and population density.Heterogeneity between studies may have occurred due
to the biases associated with cohort and case–control
studies. For the case–control studies, a selection bias may
have influenced the association if cases were selected by
a different mechanism than controls. The controls were
grouped into population- and hospital/clinic-based selec-
tion categories. For CD, only population-based controls
demonstrated a significant association with urban envir-
onment; in contrast, the urban–rural association was
insignificant in both control populations for UC. Add-
itionally, inconsistency in timing of exposure (e.g. defining
urban–rural status at time of diagnosis versus childhood)
may have contributed to the heterogeneity between case–
control studies. People in rural settings may have less
access to health care leading to under diagnosis of IBD.
Although the majority of the case–control studies were
matched by age and gender, other potential confounders
including socioeconomic status and smoking were often
not considered. Finally, studies that used administrative
databases to identify IBD patients likely introduced mis-
classification errors. Interpreting the results of meta-
analysis should be cautious because pooling data does not
address the intrinsic biases of observational studies.
Limitations in our systematic review should be consid-
ered. First, the number of studies included in the stratified
analyses was small and may have been underpowered.
Second, the quality of studies was not always optimal as
was shown with the inconsistent definitions of urban/
rural and time of exposure. Third, the included studies
used population estimates as indicators for urban envir-
onment; however, other factors that contribute to an
urban setting, such as socioeconomic characteristics, were
not considered. Finally, due to the nature of observational
studies, a temporal relationship could not be determined.
Thus, urban environment cannot be conclusively estab-
lished as a causal factor in IBD.
Conclusions
In spite of differences in study design and population
characteristics, the meta-analysis demonstrated that living
in an urban society was positively associated with the
development of IBD; though, the consistency and strength
of the association was greatest for CD. Additionally, the
meta-analysis identified important study limitations and
thus, future studies should be properly designed using a
standard definition of urban/rural. Furthermore, additional
studies are need to evaluate whether the following factors
affect the risk of developing IBD: increasing population
size (i.e. a dose response effect); a threshold value of popu-
lation size; the number of people living per unit area (i.e.
population density); and the duration and timing of expos-
ure. Finally, the meta-analysis highlights that researchers
should continue to explore for environmental differences
between urban and rural societies.
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